Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 06, 2021

SELL
$0.93 - $1.18 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$1.19 - $2.06 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

BUY
$1.62 - $3.05 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021

BUY
$1.44 - $1.98 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$0.8 - $2.33 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020

BUY
$0.75 - $1.29 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$0.33 - $1.62 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

BUY
$1.23 - $2.67 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

BUY
$1.25 - $5.0 $0 - $0
0 New
0 $0
Q4 2018

Jan 23, 2019

SELL
$4.21 - $14.28 $500 - $1,699
-119 Closed
0 $0
Q3 2018

Oct 25, 2018

BUY
$13.02 - $17.54 $1,549 - $2,087
119 New
119 $0

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.